The results showed that the exacerbation of lipid metabolic disorders caused by MT1B silencing in HepG2 and AML12 cells could be rescued by treatment with AKT inhibitor (Fig. 5A–C and Supplementary Fig. S4A–C). This evidence concerns the gene MT1B and Disorder of lipid metabolism.